Oncotelic Therapeutics, Inc. (OTLC) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $0.59 | +5800.0% |
| 2024 | $0.01 | +150.0% |
| 2023 | $-0.02 | -300.0% |
| 2022 | $0.01 | +133.3% |
| 2021 | $-0.03 | +72.7% |
| 2020 | $-0.11 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $0.59 | +5800.0% |
| 2024 | $0.01 | +150.0% |
| 2023 | $-0.02 | -300.0% |
| 2022 | $0.01 | +133.3% |
| 2021 | $-0.03 | +72.7% |
| 2020 | $-0.11 | — |